- Report
- May 2025
- 150 Pages
Global
From €5334EUR$5,950USD£4,621GBP
- Report
- January 2026
- 194 Pages
Global
From €3178EUR$3,545USD£2,754GBP
€3531EUR$3,939USD£3,059GBP
- Report
- March 2026
- 354 Pages
Global
From €5244EUR$5,850USD£4,544GBP
- Report
- February 2026
- 250 Pages
Global
From €4025EUR$4,490USD£3,487GBP
- Report
- June 2025
- 185 Pages
Global
From €4034EUR$4,500USD£3,495GBP
- Report
- June 2025
- 81 Pages
Global
From €3500EUR$4,183USD£3,139GBP
- Report
- October 2025
- 87 Pages
United States
From €4348EUR$4,850USD£3,767GBP
- Report
- November 2025
- 150 Pages
Global
From €5334EUR$5,950USD£4,621GBP
- Report
- January 2026
- 186 Pages
Global
From €3178EUR$3,545USD£2,754GBP
€3531EUR$3,939USD£3,059GBP
- Report
- January 2026
- 180 Pages
Global
From €3178EUR$3,545USD£2,754GBP
€3531EUR$3,939USD£3,059GBP
- Report
- August 2025
- 199 Pages
Global
From €3178EUR$3,545USD£2,754GBP
€3531EUR$3,939USD£3,059GBP
- Report
- March 2026
- 187 Pages
Global
From €5244EUR$5,850USD£4,544GBP
- Report
- February 2026
- 250 Pages
Global
From €4025EUR$4,490USD£3,487GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1121EUR$1,250USD£971GBP
- Report
- June 2025
- 150 Pages
Global
From €2419EUR$2,699USD£2,096GBP
- Report
- November 2025
- 150 Pages
Global
From €4348EUR$4,850USD£3,767GBP
- Report
- February 2024
- 126 Pages
Global
From €2680EUR$2,990USD£2,322GBP
- Report
- May 2024
- 129 Pages
Global
From €3585EUR$3,999USD£3,106GBP
- Report
- April 2023
- 110 Pages
Global
From €4258EUR$4,750USD£3,689GBP

The Intravenous Iron market is a segment of the Hematological Drugs market, which includes drugs used to treat anemia and other blood disorders. Intravenous Iron is a type of drug used to treat iron deficiency anemia, a condition in which the body does not have enough iron to produce healthy red blood cells. Intravenous Iron is administered directly into the bloodstream, allowing for a more rapid increase in iron levels than oral iron supplements.
Intravenous Iron is used in a variety of settings, including hospitals, clinics, and home care. It is often prescribed to patients who are unable to take oral iron supplements due to gastrointestinal issues or who require a more rapid increase in iron levels.
The Intravenous Iron market is highly competitive, with a number of companies offering products in this space. Some of the major players in the market include Vifor Pharma, Fresenius Kabi, American Regent, and B. Braun. Show Less Read more